Woodward Diversified Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
8,887
-38
-0.4% -$8.18K 0.99% 21
2026
Q1
$1.86M Sell
8,925
-375
-4% -$83.2K 0.85% 24
2025
Q4
$2.12M Buy
9,300
+297
+3% +$67.7K 0.97% 20
2025
Q3
$2.08M Sell
9,003
-8
-0.1% -$1.63K 0.97% 16
2025
Q2
$1.67M Buy
9,011
+2,254
+33% +$419K 0.85% 27
2025
Q1
$1.42M Buy
6,757
+267
+4% +$51.9K 1% 18
2024
Q4
$1.15M Sell
6,490
-2,456
-27% -$452K 0.85% 24
2024
Q3
$1.77M Sell
8,946
-211
-2% -$39.4K 1.12% 15
2024
Q2
$1.57M Buy
9,157
+467
+5% +$77.4K 0.92% 24
2024
Q1
$1.58M Buy
8,690
+515
+6% +$88.8K 0.98% 21
2023
Q4
$1.27M Sell
8,175
-449
-5% -$65.5K 0.8% 26
2023
Q3
$1.29M Buy
8,624
+668
+8% +$98.1K 0.93% 21
2023
Q2
$1.07M Buy
7,956
+11
+0.1% +$1.61K 0.81% 35
2023
Q1
$1.27M Buy
7,945
+111
+1% +$17K 1% 21
2022
Q4
$1.27M Sell
7,834
-2,473
-24% -$379K 1.02% 21
2022
Q3
$1.38M Sell
10,307
-368
-3% -$52.8K 1.14% 15
2022
Q2
$1.64M Buy
10,675
+157
+1% +$24K 1.25% 18
2022
Q1
$1.71M Sell
10,518
-3,736
-26% -$543K 1.12% 19
2021
Q4
$1.93M Buy
14,254
+23
+0.2% +$2.72K 1.14% 16
2021
Q3
$1.53M Buy
14,231
+356
+3% +$40.7K 0.96% 20
2021
Q2
$1.56M Sell
13,875
-716
-5% -$80.6K 0.89% 22
2021
Q1
$1.58M Buy
14,591
+4,103
+39% +$439K 0.93% 24
2020
Q4
$1.12M Buy
+10,488
New +$1.01M 0.73% 40

Other funds holding ABBV

Woodward Diversified Capital's ABBV Position: Q2 2026 in Review

Woodward Diversified Capital reduced its AbbVie (ABBV) stake by 0.43% in Q2 2026, selling an estimated $8.18K and leaving 8,887 shares worth $2.24M. The position accounts for 0.99% of the portfolio, ranked #21.

Woodward Diversified Capital first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Woodward Diversified Capital held 8,887 shares of AbbVie worth $2.24M as of Q2 2026.
  • Woodward Diversified Capital sold 38 AbbVie shares in Q2 2026, an estimated $8.18K.
  • AbbVie made up 0.99% of Woodward Diversified Capital's portfolio in Q2 2026, its #21 holding.
  • Woodward Diversified Capital first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Woodward Diversified Capital's 13F filing for Q2 2026, filed 28 Jul 2026.